# WATCH: Trump administration officials announce PTSD research funding for psychedelic drug ibogaine

- URL: https://talkfuse.com/story/watch-trump-administration-officials-announce-ptsd-research-funding-for-psychedelic-drug-ibogaine/
- Published: 2026-11-12T21:58:26+00:00
- Updated: 2026-11-12T22:25:58+00:00
- Original publisher: PBS NewsHour (publisher lean: Centre)
- Original article: https://www.pbs.org/newshour/politics/watch-trump-administration-officials-announce-ptsd-research-funding-for-psychedelic-drug-ibogaine
- Topics: Government, Health, Medicine, Politics

## Key points

- Up to $4.9 million will prepare US ibogaine studies.
- The initial focus is PTSD, with no patient research funded yet.
- Safety concerns have slowed research into the illegal drug.

## Summary

Federal officials have allocated up to $4.9 million to prepare for US studies of ibogaine as a possible treatment for post-traumatic stress disorder. The announcement matters because research on the drug has been largely stalled for decades, while veterans and advocates argue it could help with severe mental health and addiction conditions.

The funding will support work on manufacturing, dosing and study design, rather than research involving patients. Ibogaine, derived from a West African shrub, can cause serious side effects, including potentially fatal heart rhythm problems, and remains illegal in the US. The government will receive data and treatment guidance from Beond Inc., which says it has treated more than 3,000 people in Mexico; treatment there typically costs $10,000 to $20,000.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.